← Leaderboards
Stefan Gravenstein
Providence Va Medical Center
$2,190,723
Attributed
$4,717,489
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,717,489 · 1
VA$0 · 1
By mechanism
R01$4,717,489 · 1
I01$0 · 1
Top collaborators
- David H Canaday5 shared
- Christine D Jones3 shared
- Mark James Cameron1 shared
Most similar at Providence Va Medical Center
Same institution · by research overlap
- Christine D Jones$1,788,755
Others in their field
Other Emerging Leaders on “Hospitalization”
- Beth Baseler · Leidos Biomedical Research, Inc.$105,136,677
- Ted Ross · University Of Georgia$68,763,143
- Abraham Aizer Brody · New York University School Of Medicine$40,089,349
- Xinhua Li · Nano Terra, Inc.$32,991,103
- James Dale Berry · Brigham And Women'S Hospital$20,824,388
- Tareq Al Baghdadi · Saint Joseph Mercy Health System$19,225,531
Research focus
HospitalizationLong-Term CareNursing HomesHigh RiskMortalityEffectivenessInnovationAffectAdmission ActivityResourcesEnrollmentMediatingAreaHospitalsResearch DesignAdultElderlyInfectionCessation Of LifeAgedBloodImmuneHuman Old Age (65+)Home
Grant awards (8)
Post-Acute Home Health Care for Veterans: Examining Payer Source, Quality, and Outcomes$0
I01 · FY2025 · VA · contact PI
Post-Acute Home Health Care for Veterans: Examining Payer Source, Quality, and Outcomes$0
I01 · FY2024 · VA · contact PI
Post-Acute Home Health Care for Veterans: Examining Payer Source, Quality, and Outcomes$0
I01 · FY2022 · VA · contact PI
Epidemiology, transmission and immunology of COVID-19 in nursing home residents$1,332,423
R01 · FY2021 · AI
Epidemiology, transmission and immunology of COVID-19 in nursing home residents$1,008,129
R01 · FY2020 · AI
Non-inferiority study of adjuvanted vs. high dose flu vaccine in residents of long term care$778,393
R01 · FY2020 · AI
Non-inferiority study of adjuvanted vs. high dose flu vaccine in residents of long term care$798,632
R01 · FY2019 · AI
Non-inferiority study of adjuvanted vs. high dose flu vaccine in residents of long term care$799,912
R01 · FY2018 · AI